Shanafelt Armen

Director at Protagonist Therapeutics, Inc · on record since Aug 16, 2016
10% owner at Protagonist Therapeutics, Inc · on record since Aug 16, 2016
Director at Spyre Therapeutics, Inc. · on record since May 19, 2016
10% owner at Spyre Therapeutics, Inc. · on record since May 19, 2016
Director at AMERICAN CLAIMS EVALUATION INC · on record since Jun 28, 2017
10% owner at AMERICAN CLAIMS EVALUATION INC · on record since Jun 28, 2017
Director at Surface Oncology, Inc. · on record since Apr 23, 2018
10% owner at Surface Oncology, Inc. · on record since Apr 23, 2018

Insider trading activity of Shanafelt Armen

Transactions on record: 38; since Apr 14, 2016

Open-market buys: 6; $15.3M

Open-market sells: 0

Companies traded: 4; last filing Jun 10, 2022

Figures computed from official regulatory filings — methodology.

Companies where Shanafelt Armen has traded

Surface Oncology, Inc.9 tx · $4M · Jun 10, 2022
Spyre Therapeutics, Inc.11 tx · $549.9K · Jun 9, 2022
AMERICAN CLAIMS EVALUATION INC8 tx · $3.8M · Jun 25, 2018
Protagonist Therapeutics, Inc10 tx · $7M · Jun 12, 2018

Track record of Shanafelt Armen

Statistical track record

Free

Open-market buys: 6

Last buy: Dec 13, 2021

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Shanafelt Armen

Co-insiders of Shanafelt Armen

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Surface Oncology, Inc.	Jun 10, 2022	AwardD	24,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 9, 2022	AwardD	43,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Dec 13, 2021	Buy	121,799	3.67 USD	$447K	SEC
Spyre Therapeutics, Inc.	Dec 13, 2021	Buy	14,685	3.65 USD	$53.6K	SEC
Spyre Therapeutics, Inc.	Dec 13, 2021	Buy	13,516	3.65 USD	$49.3K	SEC
Surface Oncology, Inc.	Jun 10, 2021	AwardD	17,700	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 9, 2021	AwardD	40,000	0.00 USD	$0	SEC
Surface Oncology, Inc.	Jun 12, 2020	AwardD	12,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 10, 2020	AwardD	28,100	0.00 USD	$0	SEC
Surface Oncology, Inc.	Oct 3, 2019	AwardD	16,531	0.00 USD	$0	SEC
Surface Oncology, Inc.	Jul 2, 2019	AwardD	6,937	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 7, 2019	AwardD	12,400	0.00 USD	$0	SEC
Surface Oncology, Inc.	Jun 6, 2019	AwardD	12,100	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jun 25, 2018	AwardD	10,000	0.00 USD	$0	SEC
Protagonist Therapeutics, Inc	Jun 12, 2018	AwardD	12,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 8, 2018	AwardD	18,400	0.00 USD	$0	SEC
Surface Oncology, Inc.	Apr 23, 2018	Buy	266,000	15.00 USD	$4M	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtherD	-7,000,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Other	3,181,817	—	—	SEC
Spyre Therapeutics, Inc.	Dec 5, 2017	AwardD	30,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 27, 2017	AwardD	20,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-3,390,885	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-1,907,373	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-1,654,411	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-1,443,972	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Surface Oncology, Inc.	Jun 10, 2022	AwardD	24,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 9, 2022	AwardD	43,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Dec 13, 2021	Buy	121,799	3.67 USD	$447K	SEC
Spyre Therapeutics, Inc.	Dec 13, 2021	Buy	14,685	3.65 USD	$53.6K	SEC
Spyre Therapeutics, Inc.	Dec 13, 2021	Buy	13,516	3.65 USD	$49.3K	SEC
Surface Oncology, Inc.	Jun 10, 2021	AwardD	17,700	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 9, 2021	AwardD	40,000	0.00 USD	$0	SEC
Surface Oncology, Inc.	Jun 12, 2020	AwardD	12,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 10, 2020	AwardD	28,100	0.00 USD	$0	SEC
Surface Oncology, Inc.	Oct 3, 2019	AwardD	16,531	0.00 USD	$0	SEC
Surface Oncology, Inc.	Jul 2, 2019	AwardD	6,937	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 7, 2019	AwardD	12,400	0.00 USD	$0	SEC
Surface Oncology, Inc.	Jun 6, 2019	AwardD	12,100	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jun 25, 2018	AwardD	10,000	0.00 USD	$0	SEC
Protagonist Therapeutics, Inc	Jun 12, 2018	AwardD	12,000	0.00 USD	$0	SEC
Spyre Therapeutics, Inc.	Jun 8, 2018	AwardD	18,400	0.00 USD	$0	SEC
Surface Oncology, Inc.	Apr 23, 2018	Buy	266,000	15.00 USD	$4M	SEC
Surface Oncology, Inc.	Apr 23, 2018	OtherD	-7,000,000	—	—	SEC
Surface Oncology, Inc.	Apr 23, 2018	Other	3,181,817	—	—	SEC
Spyre Therapeutics, Inc.	Dec 5, 2017	AwardD	30,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 27, 2017	AwardD	20,000	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-3,390,885	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-1,907,373	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-1,654,411	0.00 USD	$0	SEC
AMERICAN CLAIMS EVALUATION INC	Jul 7, 2017	OtherD	-1,443,972	0.00 USD	$0	SEC